NCT04482608View on ClinicalTrials.gov

The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival

CompletedOBSERVATIONAL

Enrollment

671

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

June 8, 2020

Conditions

Colorectal Cancer MetastaticMismatch Repair DeficiencyMicrosatellite Instability High

Trial Locations (1)

510060

Sun yat-sen university cancer center, Guangzhou

All Listed Sponsors

collaborator

The Second Affiliated Hospital of Kunming Medical University

OTHER

lead

Sun Yat-sen University

OTHER

NCT04482608 - The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival | Biotech Hunter | Biotech Hunter